de la Peña IC - Search Results

1

Attention-Deficit/Hyperactivity Disorder Predominantly Inattentive Subtype/Presentation: Research Progress and Translational Studies.

de la Peña IC, Pan MC, Thai CG, Alisso T. de la Peña IC, et al. Brain Sci. 2020 May 14;10(5):292. doi: 10.3390/brainsci10050292. Brain Sci. 2020. PMID: 32422912 Free PMC article. Review.

2

Review of Plant Extracts and Active Components: Mechanisms of Action for the Treatment of Obesity-Induced Cognitive Impairment.

de la Peña I, Afable T, Dahilig-Talan VR, Cruz P. de la Peña I, et al. Brain Sci. 2023 Jun 8;13(6):929. doi: 10.3390/brainsci13060929. Brain Sci. 2023. PMID: 37371407 Free PMC article. Review.

3

Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injury.

Liska MG, Dela Peña I. Liska MG, et al. Brain Circ. 2017 Jul-Sep;3(3):143-151. doi: 10.4103/bc.bc_19_17. Epub 2017 Oct 12. Brain Circ. 2017. PMID: 30276316 Free PMC article. Review.

4

Combination therapy for ischemic stroke: Novel approaches to lengthen therapeutic window of tissue plasminogen activator.

Knecht T, Borlongan C, Dela Peña I. Knecht T, et al. Brain Circ. 2018 Jul-Sep;4(3):99-108. doi: 10.4103/bc.bc_21_18. Epub 2018 Oct 9. Brain Circ. 2018. PMID: 30450415 Free PMC article. Review.

5

Methylphenidate self-administration and conditioned place preference in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.

dela Peńa IC, Ahn HS, Choi JY, Shin CY, Ryu JH, Cheong JH. dela Peńa IC, et al. Behav Pharmacol. 2011 Feb;22(1):31-9. doi: 10.1097/FBP.0b013e328342503a. Behav Pharmacol. 2011. PMID: 21160423

6

5,7-Dihydroxy-6-methoxy-4'-phenoxyflavone, a derivative of oroxylin A improves attention-deficit/hyperactivity disorder (ADHD)-like behaviors in spontaneously hypertensive rats.

dela Peña IC, Young Yoon S, Kim Y, Park H, Man Kim K, Hoon Ryu J, Young Shin C, Hoon Cheong J. dela Peña IC, et al. Eur J Pharmacol. 2013 Sep 5;715(1-3):337-44. doi: 10.1016/j.ejphar.2013.05.002. Epub 2013 May 23. Eur J Pharmacol. 2013. PMID: 23707903

7

Adjunctive Therapy Approaches for Ischemic Stroke: Innovations to Expand Time Window of Treatment.

Knecht T, Story J, Liu J, Davis W, Borlongan CV, Dela Peña IC. Knecht T, et al. Int J Mol Sci. 2017 Dec 19;18(12):2756. doi: 10.3390/ijms18122756. Int J Mol Sci. 2017. PMID: 29257093 Free PMC article. Review.

8

Extension of Tissue Plasminogen Activator Treatment Window by Granulocyte-Colony Stimulating Factor in a Thromboembolic Rat Model of Stroke.

Dela Peña IC, Yang S, Shen G, Fang Liang H, Solak S, Borlongan CV. Dela Peña IC, et al. Int J Mol Sci. 2018 May 31;19(6):1635. doi: 10.3390/ijms19061635. Int J Mol Sci. 2018. PMID: 29857523 Free PMC article.

9

Hypothesis: Amelioration of obesity-induced cognitive dysfunction via a lorcaserin-betahistine combination treatment.

Dela Peña IC, Figueroa JD, Shi WX. Dela Peña IC, et al. Pharmacol Res Perspect. 2022 Jun;10(3):e00947. doi: 10.1002/prp2.947. Pharmacol Res Perspect. 2022. PMID: 35599337 Free PMC article.

10

Inhibition of intestinal motility by the putative BK(Ca) channel opener LDD175.

Dela Peña IC, Yoon SY, Kim SM, Lee GS, Park CS, Kim YC, Cheong JH. Dela Peña IC, et al. Arch Pharm Res. 2009 Mar;32(3):413-20. doi: 10.1007/s12272-009-1315-x. Epub 2009 Apr 23. Arch Pharm Res. 2009. PMID: 19387586

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters